Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients

Abstract
Monoclonal antibodies are accepted as ideal adjuvant therapeutic reagents for all kinds of diseases. Polyvalent (cross-linking) and low-mutated IgM antibodies (less immunogenic) are believed to be the most effective weapons against cancer. The best s

This publication has 0 references indexed in Scilit: